[3P-851] Investigation of the colonization mechanisms in the metastasis using phosphoproteomics

^○Yumi Sato^1,2, Masahiro Inoue³, Takeshi Tomonaga², Jun Adachi² (1.Dept. Basic Pathol., Fukushima Med. Univ, 2.Proteome Res., NIBION, 3.Clin. Bio. Res. Dev., Grad. Sch. Med., Kyoto Univ.)

The 46th Annual Meeting of the Molecular Biology Society of Japan

[3P-852] Molecular mechanisms of suppression of Claudin-1 expression in oral cancer cell lines

^○Shoichiro Tange¹, Masashi Idogawa¹, Hideki Kawashima¹, Yasushi Sasaki², Takashi Tokino¹ (1.Med. Genome Sci., Inst. Frontier Med., Sapporo Med. Univ., 2.Dept. Biol., Center for Med. Edu., Sapporo Med. Univ.)

The 46th Annual Meeting of the Molecular Biology Society of Japan

[3P-853] Functions of Galanin Receptors in Invasion of Human Colorectal Cancer Cells

^○Juri Tashima¹, KAZUKI KAJIZUKA², KOSUKE TASHIRO² (1.Lab. of GRT, Fac. of Agr, Kyushu Univ., 2.Kyushu Univ.)

The 46th Annual Meeting of the Molecular Biology Society of Japan

[3P-854] Investigating the action mechanism of a cancer-preventive drug candidate using zebrafish model

^○Shinsaku Yoshida^1,2, Yukinari Haraoka¹, Yuki Akieda¹, Tohru Ishitani^1,2 (1.Dept. of Homeostatic Regulation, RIMD, Osaka Univ., 2.Dept. of Biol. Sci., Grad. Sch. of Sci., Osaka Univ.)

The 46th Annual Meeting of the Molecular Biology Society of Japan

[3P-855] The mechanism of maintenance of HER2 expression in breast cancer

^○Shota Katayama¹, Jun Nakayama², Kentaro Semba^1,3 (1.Dept. of Life Sci. & Biomed. Sci., Grad. Sch. of Sci. & Eng., Waseda Univ., 2.Dept. of Oncogenesis Growth Regulation, Res Inst., Osaka Intl. Cancer Inst., 3.TR center, Univ. of Fukushima Med.)

The 46th Annual Meeting of the Molecular Biology Society of Japan

[3P-856_3SP-10-05] Toll-Like Receptor 9 Activation Induces Immune Responses and Phosphatidylserine Exposure on Tumor Resulting in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting Prodrug

^○JenChih Tseng¹, JingXing Yang¹, ChiaYin Lee¹, YiLing Liu¹, Lun K Tsou², TsungHsien Chuang¹ (1.Immunology Research Center, NHRI, 2.Institute of Biotechnology and Pharmaceutical Research, NHRI)

The 46th Annual Meeting of the Molecular Biology Society of Japan

[3P-857] Novel molecular targeted cancer therapy by p53 pathway activation via the nucleolar stress response

^○Kohichi Kawahara¹, Tatsuhiko Furukawa² (1.Dep. Mol. Onc. Grad. Sch. Med. Dent. Sci. Kagoshima Univ, 2.Dep. Pathology. Grad. Sch. Med. Dent. Sci. Kagoshima Univ)

The 46th Annual Meeting of the Molecular Biology Society of Japan

[3P-858_3SP-10-06] NF-kB is a potential therapeutic target for histone deacetylase inhibitor-resistant cutaneous T-cell lymphoma.

^○Yuto Takahashi¹, Akihiro Kitadate², Sho Ikeda², Sayaka Iwama¹, Ko Abe², Wataru Kuroki², Masahiro Yamada², Hiroyuki Tagawa², Hideki Wakui¹, Naoto Takahashi² (1.Dept. of Life Sci., Grad. Sch. of Eng. Sci., Univ. of Akita, 2.Dept. of Hematology, Nephrology, and Rheumatology, Grad. Sch. of Med., Univ. of Akita)

The 46th Annual Meeting of the Molecular Biology Society of Japan

[3P-859] An analysis of DKK1-CKAP4 signal axis as a prognostic factor and potential therapeutic target of hepatocellular carcinoma

^○Ryota Sada, Kosuke Iguchi, Hirokazu Kimura, Shinji Matsumoto, Akira Kikuchi (Dept. of Mol. Bio. and Biochem., Grad. Sch. of Med., Univ. of Osaka)

The 46th Annual Meeting of the Molecular Biology Society of Japan

[3P-860_3SP-11-02] Combination of tankyrase inhibitors and immune checkpoint inhibitors for anticancer efficacy

^○Shiho Tsuruta^1,2, Tetsuo Mashima¹, Xunmei Yuan¹, Fumiyuki Shirai³, Hiroyuki Seimiya^1,2 (1.Div. Mol. Biother., Cancer Chemother. Ctr., JFCR, 2.CBMS, Grad. Sch. of Frontier Sciences, Univ. of Tokyo, 3.Unit. Drug. Discov., RIKEN CSRS)

The 46th Annual Meeting of the Molecular Biology Society of Japan